SABRA GENTRY: Open Payments
NPI 1164827218 · CARTHAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 50 payments from 11 companies in 2025. Trend: 2023 $748 · 2024 $942 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $224 |
| Novo Nordisk Inc | 11 | $196 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| Corcept Therapeutics | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Hologic Sales and Service, LLC | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: VRAYLAR, Wegovy, Korlym, AIRSUPRA, CAPLYTA, APTIMA, GEMTESA, Rybelsus.
Industry payments across TN — which companies pay providers there.
